Pasithea Therapeutics Corp. (KTTA)

USD 2.54

(-4.51%)

Market Cap (In USD)

3.21 Million

Revenue (In USD)

-

Net Income (In USD)

-15.96 Million

Avg. Volume

17.79 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.52-9.4
PE
-
EPS
-
Beta Value
0.821
ISIN
US70261F2020
CUSIP
70261F103
CIK
1841330
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Tiago Reis Marques M.D., Ph.D.
Employee Count
-
Website
https://www.pasithea.com
Ipo Date
2021-09-15
Details
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.